Book your demo

Want to know how Resilience Care can support your teams and projects? Contact us !

Category

Oncology
Testimonials

Written by

Summary

Title

Elevating Patient Insights: PROs as Essential Endpoint in Phase III & IV Clinical Trials

Expert Prof. Massimo di Maio explains why Phase III & IV oncology trials must elevate Patient-Reported Outcomes (PROs). Discover how integrating Quality of Life as a key endpoint and using large-scale data collection delivers valuable, actionable insights.

Dec 9, 2025

4 minutes

Watch Prof. Massimo Di Maio, Medical Oncologist, Head of the Medical Oncology Unit at Molinette Hospital (Turin), and President-elect of AIOM, discuss the strategic importance of Patient-Reported Outcomes (PROs) in late-stage research. He explains why integrating Quality of Life (QoL) as a key endpoint in Phase III & IV oncology trials is essential. Learn how new methods of large-scale data collection can capture the patient voice to deliver valuable and actionable insights for better treatments.

Heading

Elevating Patient Insights: PROs as Essential Endpoint in Phase III & IV Clinical Trials

Expert Prof. Massimo di Maio explains why Phase III & IV oncology trials must elevate Patient-Reported Outcomes (PROs). Discover how integrating Quality of Life as a key endpoint and using large-scale data collection delivers valuable, actionable insights.

Dec 9, 2025

4 minutes

Watch Prof. Massimo Di Maio, Medical Oncologist, Head of the Medical Oncology Unit at Molinette Hospital (Turin), and President-elect of AIOM, discuss the strategic importance of Patient-Reported Outcomes (PROs) in late-stage research. He explains why integrating Quality of Life (QoL) as a key endpoint in Phase III & IV oncology trials is essential. Learn how new methods of large-scale data collection can capture the patient voice to deliver valuable and actionable insights for better treatments.

Elevating Patient Insights: PROs as Essential Endpoint in Phase III & IV Clinical Trials

Expert Prof. Massimo di Maio explains why Phase III & IV oncology trials must elevate Patient-Reported Outcomes (PROs). Discover how integrating Quality of Life as a key endpoint and using large-scale data collection delivers valuable, actionable insights.

Dec 9, 2025

4 minutes

Watch Prof. Massimo Di Maio, Medical Oncologist, Head of the Medical Oncology Unit at Molinette Hospital (Turin), and President-elect of AIOM, discuss the strategic importance of Patient-Reported Outcomes (PROs) in late-stage research. He explains why integrating Quality of Life (QoL) as a key endpoint in Phase III & IV oncology trials is essential. Learn how new methods of large-scale data collection can capture the patient voice to deliver valuable and actionable insights for better treatments.

Elevating Patient Insights: PROs as Essential Endpoint in Phase III & IV Clinical Trials

Expert Prof. Massimo di Maio explains why Phase III & IV oncology trials must elevate Patient-Reported Outcomes (PROs). Discover how integrating Quality of Life as a key endpoint and using large-scale data collection delivers valuable, actionable insights.

Dec 9, 2025

4 minutes

Watch Prof. Massimo Di Maio, Medical Oncologist, Head of the Medical Oncology Unit at Molinette Hospital (Turin), and President-elect of AIOM, discuss the strategic importance of Patient-Reported Outcomes (PROs) in late-stage research. He explains why integrating Quality of Life (QoL) as a key endpoint in Phase III & IV oncology trials is essential. Learn how new methods of large-scale data collection can capture the patient voice to deliver valuable and actionable insights for better treatments.

Elevating Patient Insights: PROs as Essential Endpoint in Phase III & IV Clinical Trials

Expert Prof. Massimo di Maio explains why Phase III & IV oncology trials must elevate Patient-Reported Outcomes (PROs). Discover how integrating Quality of Life as a key endpoint and using large-scale data collection delivers valuable, actionable insights.

Dec 9, 2025

4 minutes

Watch Prof. Massimo Di Maio, Medical Oncologist, Head of the Medical Oncology Unit at Molinette Hospital (Turin), and President-elect of AIOM, discuss the strategic importance of Patient-Reported Outcomes (PROs) in late-stage research. He explains why integrating Quality of Life (QoL) as a key endpoint in Phase III & IV oncology trials is essential. Learn how new methods of large-scale data collection can capture the patient voice to deliver valuable and actionable insights for better treatments.

Speakers:

Prof. Massimo di Maio
Medical Oncologist — Head of the Medical Oncology Unit at Molinette Hospital — Professor at Turin's University — President-elect of AIOM
Turin, Italy

Related articles

Oncology
Testimonials

Elevating Patient Insights: PROs as Essential Endpoint in Phase III & IV Clinical Trials

Dec 9, 2025

4 minutes

Oncology
Testimonials

Pioneering Early Phase Trials: PROs and Dose Optimization

Dec 9, 2025

3 minutes

Oncology
Online Conferences

Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI

Dec 4, 2025

15 minutes

Ready to Implement 
Resilience in your Facility ?

Let’s discuss how our solutions can help you unlock the full potential of your data and improve patient outcomes.